Phase II study of VAC1.2(vincristine, actinomycin-D, cyclophosphamide) therapy for patients with newly diagnosed low-risk subset A rhabdomyosarcoma.

Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2020
This article has no abstract
Epistemonikos ID: 1bc49590931d72350a62cc2f5c3440f6e61511a4
First added on: Apr 09, 2025